Your browser doesn't support javascript.
loading
Inhibition of ErbB kinase signalling promotes resolution of neutrophilic inflammation.
Rahman, Atiqur; Henry, Katherine M; Herman, Kimberly D; Thompson, Alfred Ar; Isles, Hannah M; Tulotta, Claudia; Sammut, David; Rougeot, Julien Jy; Khoshaein, Nika; Reese, Abigail E; Higgins, Kathryn; Tabor, Caroline; Sabroe, Ian; Zuercher, William J; Savage, Caroline O; Meijer, Annemarie H; Whyte, Moira Kb; Dockrell, David H; Renshaw, Stephen A; Prince, Lynne R.
Afiliación
  • Rahman A; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.
  • Henry KM; Department of Biochemistry and Molecular Biology, Faculty of Biological Sciences, University of Dhaka, Dhaka, Bangladesh.
  • Herman KD; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.
  • Thompson AA; The Bateson Centre, University of Sheffield, Sheffield, United Kingdom.
  • Isles HM; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.
  • Tulotta C; The Bateson Centre, University of Sheffield, Sheffield, United Kingdom.
  • Sammut D; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.
  • Rougeot JJ; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.
  • Khoshaein N; The Bateson Centre, University of Sheffield, Sheffield, United Kingdom.
  • Reese AE; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.
  • Higgins K; The Bateson Centre, University of Sheffield, Sheffield, United Kingdom.
  • Tabor C; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.
  • Sabroe I; Institute of Biology, Leiden University, Leiden, Netherlands.
  • Zuercher WJ; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.
  • Savage CO; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.
  • Meijer AH; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.
  • Whyte MK; The Bateson Centre, University of Sheffield, Sheffield, United Kingdom.
  • Dockrell DH; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.
  • Renshaw SA; SGC-UNC, Division of Chemical Biology and Medicinal Chemistry, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, United States.
  • Prince LR; Immuno-Inflammation Therapy Area Unit, GlaxoSmithKline Research and Development Ltd, Stevenage, United Kingdom.
Elife ; 82019 10 15.
Article en En | MEDLINE | ID: mdl-31613219

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infecciones por Pseudomonas / Neumonía Bacteriana / Inflamación / Pulmón / Neutrófilos Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Elife Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infecciones por Pseudomonas / Neumonía Bacteriana / Inflamación / Pulmón / Neutrófilos Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Elife Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Reino Unido